On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at their May 2023 meeting. Actions in this consultation include:
- Fosfomycin 3g oral sachets for uncomplicated UTI in non-pregnant women – to be GREEN
- Tezepelumab for severe asthma – to be RED
All links to MHRA drug safety updates will be added to formulary as appropriate.
To take part in this consultation, visit the consultations page. The consultation period is open until 5pm on Friday 23rd June 2023.